Home/Filings/4/0001192482-19-000182
4//SEC Filing

Malamut Richard 4

Accession 0001192482-19-000182

CIK 0001267565other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:15 PM ET

Size

7.7 KB

Accession

0001192482-19-000182

Insider Transaction Report

Form 4
Period: 2019-04-01
Malamut Richard
EVP and Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-04-01+42,50042,500 total
  • Award

    Stock Option (Right to Purchase)

    2019-04-01+85,00085,000 total
    Exercise: $15.12Exp: 2029-04-01Common Stock (85,000 underlying)
Footnotes (2)
  • [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on April 1, 2020, and the balance of the restricted stock units vest in equal annual installments (in each case, rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
  • [F2]Twenty-five percent (25%) of the option vests and becomes exercisable on April 1, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three year period, subject to the reporting person's continued service with the issuer.

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1
  • filerCIK 0001772168

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:15 PM ET
Size
7.7 KB